|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Activyl täpilahus suurtele kassidele
|
|
Active substances:
|
|
|
ATC code:
|
QP53AX27
|
|
Dosage form:
|
spot-on solution
|
|
Strength:
|
200mg
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
Treatment and prevention of flea infestation (Ctenocephalides felis). Efficacy against new infestations with fleas persists for 4 weeks following a single application.
The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl treated pets.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Intervet International B.V.
|
|
Marketing authorization number:
|
EU/2/10/118
|
|
Marketing authorization issued on:
|
February 18, 2011
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1519668
|
Activyl täpilahus suurtele kassidele
|
spot-on solution
|
200mg 1.03ml 1TK
|
Prescription
|
|
|
|
|
kassidele
|
|
1519679
|
Activyl täpilahus suurtele kassidele
|
spot-on solution
|
200mg 1.03ml 4TK
|
Prescription
|
|
|
|
|
kassidele
|
|
1592704
|
Activyl täpilahus suurtele kassidele
|
spot-on solution
|
200mg 1.03ml 6TK
|
Prescription
|
|
|
|
|
kassidele
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere